MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions (NCT05908331)
MagicTouch Sirolimus-coated Balloon for Treatment of In-Stent Restenosis in Coronary Artery Lesions
🩺 Plain-English Summary (8th-Grade Level)
A Prospective, Multicenter, Randomized, Two-Arm, Single-blind Superiority Trial to Evaluate the Safety and Efficacy of the MagicTouch™ Sirolimus- Coated Balloon in the Treatment of Coronary Drug-Eluting Stent In-Stent Restenosis. Subjects with prior DES implantation presenting with ISR lesions undergoing PCI will be randomized into two groups: treatment with the MagicTouch™ sirolimus-coated balloon or POBA on a 2:1 basis. Approximately 492 subjects will be enrolled in the randomized study in a maximum of 50 study sites located in the United States. The goal is to establish the safety and efficacy of the MagicTouch™ sirolimus- coated balloon in treatment of coronary in-stent restenosis (ISR).
Who can join: Review the eligibility criteria below.
Location: Cardiology, PC - Princeton Baptist Medical Center — Birmingham, Alabama
Age range: 18 Years to 110 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (28 Sites)
Showing the first 25 of 28 sites.
- Cardiology, PC - Princeton Baptist Medical Center — Birmingham, Alabama
- Dignity Health - Mercy Gilbert Medical Center — Gilbert, Arizona
- Cedars - Sinai Medical Center — Los Angeles, California
- Yale University / Yale New Haven Hospital — New Haven, Connecticut
- Cheek-Powell Heart and Vascular Pavilion — Clearwater, Florida
- Clearwater Cardiovascular and Interventional Consultants — Clearwater, Florida
- The Cardiac & Vascular Institute Research Foundation — Gainesville, Florida
- Tampa General Hospital / University of South Florida — Tampa, Florida
- Atlanta VA Medical Center — Decatur, Georgia
- Beth Israel Deaconess Medical Center — Boston, Massachusetts
- Metropolitan Heart and Vascular Institute — Coon Rapids, Minnesota
- Minneapolis Heart Institute Foundation — Minneapolis, Minnesota
- Cardiology Associates Research, LLC — Tupelo, Mississippi
- Cardiology Associates Research, LLC — Tupelo, Mississippi
- AtlantiCare Regional Medical Center — Pomona, New Jersey
- VA New York Harbor Healthcare System — New York, New York
- NYU Langone Health — New York, New York
- Columbia University Medical Center/NYPH — New York, New York
- Montefiore Medical Center - Moses Division — The Bronx, New York
- NC Heart and Vascular Research, LLC — Raleigh, North Carolina
- Cleveland Clinic — Cleveland, Ohio
- Oklahoma University Health (OU Health) — Oklahoma City, Oklahoma
- Providence St. Vincent Medical Center — Portland, Oregon
- Prisma Health — Greenville, South Carolina
- Centennial Medical Center — Nashville, Tennessee
📞 Contact the Study Coordinator
Phone: +393292467132
Email: dario@conceptmedical.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in In-Stent Restenosis
- A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort — Tucson, Arizona
- A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) — Birmingham, Alabama
Explore by condition: All In-Stent Restenosis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.